
Title: Executive Director/Vice President, Corporate Counsel
Reports to: Chief Legal Officer
Location: Redwood City, CA
Classification: Exempt
Coherus Oncology is a public, fully integrated commercial-stage innovative oncology company with an approved next-generation programmed death receptor-1 (“PD-1”) inhibitor, LOQTORZI® (toripalimab-tpzi), and a pipeline that includes two mid-stage clinical candidates targeting liver, head and neck, colorectal and other cancers.
Coheus is seeking a local, senior contracting attorney reporting to the Company’s Chief Legal Officer. This individual will have primary responsibility for managing the contracting function at Coherus, including negotiating and drafting contracts in collaboration with business partners and administering and improving the company’s contracting processes and procedures. The individual will work closely with the Chief Legal Officer; collaborate with strategic business partners in the CEO’s office, business development, supply chain, clinical development, medical affairs, commercial, and other functions; and and will manage a paralegal and external resources as needed.
Responsibilities
Qualifications:
Qualifications:
The Base Salary Range for this position is $290,000 to $350,000. Coherus considers various factors, including professional background and work experience, when determining base pay. These considerations mean actual compensation will vary.
Coherus provides equal employment opportunities to all employees and applicants for employment and prohibits unlawful discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. We also prohibit discrimination based on the perception that anyone has any of these characteristics or is associated with a person who has or is perceived as having any of these characteristics.

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.